Back to search

Article

Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations

2020-10-08

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction</h4> Vaccination and anti-viral therapy with nucleos(t)ide analogues (NAs) are key approaches to reducing the morbidity, mortality and transmission of hepatitis B virus (HBV) infection. However, the efficacy of these interventions may be reduced by the emergence of drug resistance-associated mutations (RAMs) and/or vaccine escape mutations (VEMs). We have assimilated data on th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
23e976e6-ac1a-5879-b6b8-362c84a8d876
DOI
10.1101/2020.10.07.329391
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutationsDOI 10.1101/2020.10.07.329391
Select a neighboring publication to make it the new centre.